MedPlus Health Services Limited (NSE:MEDPLUS)
India · Delayed Price · Currency is INR 669.95
+6.50 (0.98%)
At close: Sep 9, 2026
MedPlus Health Services Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 80,484 | 100,834 | 90,967 | 82,223 | 77,513 | 121,036 | |
Market Cap Growth | -19.32% | 10.85% | 10.63% | 6.08% | -35.96% | - |
Enterprise Value | 88,592 | 106,712 | 98,583 | 89,837 | 81,173 | 126,771 |
Last Close Price | 669.95 | 839.90 | 760.00 | 687.85 | 649.70 | 1014.50 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 38.24 | 45.92 | 60.55 | 125.58 | 155.76 | 126.34 |
Forward PE | 36.97 | 42.61 | 48.95 | 83.56 | 101.15 | 82.82 |
PS Ratio | 1.11 | 1.46 | 1.48 | 1.46 | 1.70 | 3.20 |
PB Ratio | 4.08 | 5.11 | 5.23 | 5.21 | 5.20 | 8.54 |
P/TBV Ratio | 4.18 | 5.24 | 5.38 | 5.39 | 5.38 | 8.83 |
P/FCF Ratio | 21.60 | 27.07 | 18.91 | 138.57 | - | 232.01 |
P/OCF Ratio | 16.24 | 20.35 | 16.83 | 57.20 | 85.74 | 71.24 |
PEG Ratio | 1.95 | 1.85 | 1.06 | 1.25 | 3.26 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.23 | 1.55 | 1.61 | 1.60 | 1.78 | 3.35 |
EV/EBITDA Ratio | 14.79 | 25.58 | 30.44 | 43.10 | 57.51 | 67.89 |
EV/EBIT Ratio | 28.15 | 31.22 | 39.40 | 63.15 | 84.48 | 77.91 |
EV/FCF Ratio | 23.78 | 28.64 | 20.50 | 151.40 | - | 243.01 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.72 | 0.72 | 0.64 | 0.64 | 0.60 | 0.57 |
Debt / EBITDA Ratio | 2.38 | 2.29 | 2.26 | 2.77 | 3.26 | 2.90 |
Debt / FCF Ratio | - | 3.82 | 2.33 | 17.01 | - | 15.62 |
Net Debt / Equity Ratio | 0.41 | 0.42 | 0.39 | 0.54 | 0.45 | 0.56 |
Net Debt / EBITDA Ratio | 2.05 | 2.00 | 2.10 | 4.05 | 4.76 | 4.25 |
Net Debt / FCF Ratio | - | 2.23 | 1.41 | 14.23 | -8.54 | 15.21 |
Asset Turnover | - | 1.89 | 1.93 | 1.94 | 1.69 | 1.82 |
Inventory Turnover | - | 3.75 | 3.48 | 3.55 | 3.47 | 3.60 |
Quick Ratio | - | 0.93 | 0.80 | 0.36 | 0.51 | 0.10 |
Current Ratio | - | 3.00 | 3.20 | 2.98 | 3.11 | 2.92 |
Return on Equity (ROE) | - | 11.82% | 9.05% | 4.28% | 3.45% | 8.82% |
Return on Assets (ROA) | - | 5.86% | 4.91% | 3.06% | 2.23% | 4.89% |
Return on Invested Capital (ROIC) | 8.96% | 10.43% | 8.47% | 5.54% | 4.40% | 7.63% |
Return on Capital Employed (ROCE) | - | 10.50% | 9.00% | 5.70% | 4.10% | 8.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.62% | 2.18% | 1.65% | 0.80% | 0.64% | 0.79% |
FCF Yield | 4.63% | 3.69% | 5.29% | 0.72% | -1.01% | 0.43% |
Buyback Yield / Dilution | -0.00% | -0.06% | 0.00% | -0.31% | -6.38% | -3.82% |